Antiepileptic Drugs and Cerebral Glucose Metabolism

Epilepsia

Volumn 29, Issue , 1988, Pages S48-S55

  Theodore, William H ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anticonvulsants; Glucose; Phenobarbital; Phenytoin; Positron emission tomography

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN;

ADULT; BLOOD LEVEL; BRAIN METABOLISM; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL;

ANTICONVULSANTS; BRAIN; CARBAMAZEPINE; GAMMA-AMINOBUTYRIC ACID; GLUCOSE; HUMAN; PHENOBARBITAL; PHENYTOIN; RECEPTORS, GABA-A; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0023788029     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1988.tb05797.x     Document Type: Article

References (84)

1. Cerebral protective, metabolic, and vascular effects of phenytoin
2. Effect of neurotropic drugs on glucose metabolism in rat brain in vivo
3. Effects of sodium valproate and acetazolamide on cerebral respiration
4. Effects of hypnotic drugs on memory
5. Selective supres‐sion of glucose utilization in normal brain versus gliomas: positron emission tomography during barbiturate coma in humans
6. 3H‐GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography
7. Effects of diphenylhydan‐toin on selected physiological and psychological measures in normal adults
8. Intelligence in epilepsy: a prospective study in children
9. Patterns of metabolic activity in the treatment of schizophrenia
10. Influence of pheno‐barbital anesthesia on carbohydrate and amino acid metabolism in rat brain
11. ,8F]fluoro‐D‐glucose positron emission tomography
12. A comparison of the effects of pentobarbital and diphenylhydantoin on the GABA sensitivity and excitability of adult sensory ganglion cells
13. The inhibition of terminal oxidation by porphyrinogenic drugs
14. Dose dependent reduction of glucose utilization by pentobarbital in rat brain
15. Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease
16. Positron emission tomography in schizophrenic patients with and without neuroleptic medication
17. Diphenylhydantoin serum levels, toxicity, and neuropsychological performance in patients with epilepsy
18. Psychotropic effects of carbamazepine in epilepsy: a double blind comparison with phenytoin
19. Cerebral cortical metabolism reflects performance on the Wechsler adult intelligence scale
20. Alzheimer's disease: focal cortical changes shown by positron emission tomography
21. The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography
22. Mu‐opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy
23. Comparison of the effects of valproate, ethosuximide, phenytoin, and pentobarbital on cerebral energy metabolism in the rat
24. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming
25. Brain metabolism in man: unanesthetised and in pentobarbital narcosis
26. Perceptual‐motor behavior in relation to blood phenobarbital: a preliminary report
27. Acute effects of diphenylhydantoin in relation to plasma levels
28. Functional neuronal replacement by grafted striatal neurons in the ibotenic acid lesioned rat striatum
29. Valproic acid: update on its mechanisms of action
30. Specific alterations in local cerebral glucose utilization following striatal lesions
31. Effects of the putative GABAergic agonists, muscimol and THIP, upon local cerebral glucose utilization
32. The effects of the GABAergic agonist muscimol upon the relationship between local cerebral blood flow and glucose utilization
33. Cerebral glucose utilization following striatal lesions: the effects of the GABA agonist, muscimol, and the dopaminergic agonist, apomorphine
34. Cerebral blood flow in children during the interseizure period
35. Local cerebral glucose utilization in non‐rapid eye movement sleep
36. The general metabolism of the brain in vivo
37. Cerebral blood flow and metabolism in schizophrenia: their effects of barbiturate seminarcosis, insulin coma, and electroshock
38. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease
39. Pseudodegenerative disease due to di‐phenylhydantoin intoxication
40. Memory impairment in epileptic patients: selective effect of phenobarbital concentration
41. The effects of sleep and lack of sleep on the cerebral circulation and metabolism of normal young men
42. Cognitive and motor‐sensory performances in toxic and nontoxic epileptic subjects
43. Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells
44. Effects of barbiturate sedation in the brain in toxemia of pregnancy
45. The distribution of alterations in energy metabolism in the rat brain produced by apomorphine
46. Distribution of effects of haloperidol on energy metabolism in the rat brain
47. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture
48. The effects of chronic diphenylhydantoin administration on cerebral metabolism in the adult rat
49. On the dissimilar effects of drugs on the digit symbol substitution and continuous performance tests
50. Regional changes of cerebral blood flow during haloperidol therapy in patients with paranoid symptoms
51. Drug interactions and the GABA receptor ionophor complex
52. Chloride‐dependent enhancement by barbiturates of 7‐aminobutyric acid receptor binding
53. Effects of gamma‐aminobutyric acid agonist and antagonist drugs on local cerebral glucose utilization
54. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18) 2‐fluoro‐2‐deoxy‐D‐glucose: validation of method
55. Tomographic mapping of human cerebral metabolism: visual stimulation and deprivation
56. 11) glucose for the determination of local cerebral glucose metabolism in humans: variation within and between subjects
57. Serum anticonvulsant concentrations in epileptic patients with mental symptoms
58. Normal sleep: regional cerebral hemodynamics
59. 11C‐RO 15–1788, a benzodiazepine antagonist, studied in human brain in vivo by positron emission tomography
60. Inhibition of amino acid transmitter release from rat brain slices by phenytoin and related anticonvulsants
61. Relation between physiological function and energy metabolism in the central nervous system
62. Circulation and energy metabolism of the brain
63. The influence of anticonvulsant drugs on formyl tetrahydrofolic acid stimulation of rat brain respiration in vitro
64. Rates of cerebral glucose utilization in rats anesthetised with phenobarbitone
65. Diazepam and (‐) pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of 7‐aminobutyric acid responses in cultured central neurons
66. The effect of phenytoin on human cerebral glucose metabolism
67. Barbiturates reduce human cerebral glucose metabolism
68. Complex partial seizures: cerebellar metabolism
69. Patterns of cerebral glucose metabolism in patients with partial seizures
70. Carbamazepine and cerebral glucose metabolism
71. Removal of sedative‐hypnotic anti‐epileptic drugs from the regimens of patients with intractable epilepsy
72. Cerebral glucose metabolism in the Lennox‐Gastaut syndrome
73. Anticonvulsant serum levels: relationship to impairments of cognitive functioning
74. Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy
75. Human cerebral blood flow during sleep and waking
76. Progressive encephalopathy due to chronic hydantoin intoxication
77. Valproate reduces excitability by blockage of sodium and potassium conductance
78. Effects of phenobarbital and sodium valproate on neuropsychological function and behavior
79. Blood flow and oxygen consumption of the human brain during anesthesia produced by thiopental
80. 3H] batrach‐otoxinin A 20‐a‐benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine
81. Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage‐sensitive sodium channels in neuroblastoma cells
82. Inhibition of voltage‐sensitive sodium channels in neuroblastoma cells and synapto‐somes by the anticonvulsant drugs diphenyhydantoin and carbamazepine
83. Phenytoin: proposed mechanisms of anticonvulsant action
84. Site of anticonvulsant action on sodium channels: autoradiographic and electrophysiologic studies in rat brain